Eslicarbazepine
Back to searchMolecule Structure
Scientific Name
Eslicarbazepine
Description of the Drug
Eslicarbazepine is an antiepileptic indicated as a monotherapy or adjunct therapy in the treatment of epilepsy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14575
http://www.drugbank.ca/drugs/DB14575
Brand Name(s)
Erelib, Pazzul, Stedesa
Company Owner(s)
Not Available
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Sodium channel alpha subunit | PROTEIN FAMILY | BLOCKER | CHEMBL2331043 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL418933 |
| Human Metabolome Database | HMDB0060702 |
| DrugBank | DB14575 |
| PubChem: Thomson Pharma | 14847818 |
| PubChem | 9881504 |
| Nikkaji | J514.997E |
| ChemicalBook | CB9500846 |
| Guide to Pharmacology | 7350 |
| rxnorm | ESLICARBAZEPINE |
| ChEBI | 174358 |
| ZINC | ZINC000000896938 |
